Last updated on September 2018

Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies


Brief description of study

This is a standard of care treatment guideline for allogeneic hematopoetic stem cell transplant (HSCT) in patients with primary immune deficiencies.

Detailed Study Description

Based on diagnosis and clinical history, a determination of the most appropriate regimen will be made based on the following prep plans:

Arm A: Fully Myeloablative Preparative Regimen, Arm B: Reduced Toxicity Ablative Preparative Regimen, Arm C: Reduced Intensity Conditioning, Arm D: No Preparative Regimen

Clinical Study Identifier: NCT01652092

Contact Investigators or Research Sites near you

Start Over

Angela R. Smith, M.D.

Masonic Cancer Center, University of Minnesota
Minneapolis, MN United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.